Click on image to view larger version.

Figure 2 Overall Clinical Outcomes

Two-year cumulative mortality, repeat nonfatal myocardial infarction (MI), infarct-related artery lesion repeat revascularization (TLR), infarct-related artery repeat revascularization (TVR), and major adverse cardiac event (MACE) (death, MI, TVR) rates of patients treated with drug-eluting stents.